Gene: MET ×
Source: CURATED ×
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 SomaticCausalMutation disease ORPHANET Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma. 26536169 2016
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CTD_human Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. 25401301 2015
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN c-Met inhibitors with novel binding mode show activity against several hereditary papillary renal cell carcinoma-related mutations. 18055465 2008
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN The MET oncogene drives a genetic programme linking cancer to haemostasis. 15772665 2005
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN Activating Met mutations produce unique tumor profiles in mice with selective duplication of the mutant allele. 15557554 2004
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. 10433944 1999
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. 9140397 1997
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN Activating mutations for the met tyrosine kinase receptor in human cancer. 9326629 1997
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 Biomarker disease CLINGEN The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. 1917129 1991
Entrez Id: 4233
Gene Symbol: MET
MET 		0.800 CausalMutation disease CGI